Bengaluru: HCL Technologies has signed a multi-year contract with biotechnology firm Genmab to support its IT infrastructure operations globally, it said, without disclosing the deal value. HCL will support Genmab’s IT operations through a new future-proof digital foundation that spans hybrid cloud, cybersecurity, unified service management and digital workplace services, it said.
HCL’s centralised global service delivery model and innovative frameworks will enable Genmab to realise greater automation, improved cost transparency, enhanced operational efficiency and increased control, it added.
